399 related articles for article (PubMed ID: 30617121)
41. Influenza Vaccines toward Universality through Nanoplatforms and Given by Microneedle Patches.
Tang S; Zhu W; Wang BZ
Viruses; 2020 Oct; 12(11):. PubMed ID: 33114336
[TBL] [Abstract][Full Text] [Related]
42. Extending the Breadth of Influenza Vaccines: Status and Prospects for a Universal Vaccine.
Fox A; Quinn KM; Subbarao K
Drugs; 2018 Sep; 78(13):1297-1308. PubMed ID: 30088204
[TBL] [Abstract][Full Text] [Related]
43. [Technical guidelines for seasonal influenza vaccination in China (2020-2021)].
National Immunization Advisory Committee Technical Working Group
Zhonghua Yu Fang Yi Xue Za Zhi; 2020 Oct; 54(10):1035-1059. PubMed ID: 33131228
[TBL] [Abstract][Full Text] [Related]
44. Targeting Antigens for Universal Influenza Vaccine Development.
Nguyen QT; Choi YK
Viruses; 2021 May; 13(6):. PubMed ID: 34073996
[TBL] [Abstract][Full Text] [Related]
45. Influenza vaccination and the risk of COVID-19 infection and severe illness in older adults in the United States.
Huang K; Lin SW; Sheng WH; Wang CC
Sci Rep; 2021 May; 11(1):11025. PubMed ID: 34040014
[TBL] [Abstract][Full Text] [Related]
46. Influenza: a case for an improved link between vaccine research and public health.
Palache AM
Immunol Lett; 2009 Feb; 122(2):137. PubMed ID: 19100772
[No Abstract] [Full Text] [Related]
47. Influenza and Antibody-Dependent Cellular Cytotoxicity.
Von Holle TA; Moody MA
Front Immunol; 2019; 10():1457. PubMed ID: 31316510
[TBL] [Abstract][Full Text] [Related]
48. Cell culture-derived flu vaccine: Present and future.
Pérez Rubio A; Eiros JM
Hum Vaccin Immunother; 2018; 14(8):1874-1882. PubMed ID: 29672213
[TBL] [Abstract][Full Text] [Related]
49. Development and approval of live attenuated influenza vaccines based on Russian master donor viruses: Process challenges and success stories.
Rudenko L; Yeolekar L; Kiseleva I; Isakova-Sivak I
Vaccine; 2016 Oct; 34(45):5436-5441. PubMed ID: 27593158
[TBL] [Abstract][Full Text] [Related]
50. Novel Approaches for The Development of Live Attenuated Influenza Vaccines.
Blanco-Lobo P; Nogales A; Rodríguez L; Martínez-Sobrido L
Viruses; 2019 Feb; 11(2):. PubMed ID: 30813325
[TBL] [Abstract][Full Text] [Related]
51. Universal influenza vaccines: a realistic option?
de Vries RD; Altenburg AF; Rimmelzwaan GF
Clin Microbiol Infect; 2016 Dec; 22 Suppl 5():S120-S124. PubMed ID: 27130671
[TBL] [Abstract][Full Text] [Related]
52. Universal influenza vaccines, science fiction or soon reality?
de Vries RD; Altenburg AF; Rimmelzwaan GF
Expert Rev Vaccines; 2015; 14(10):1299-301. PubMed ID: 26104835
[TBL] [Abstract][Full Text] [Related]
53. M2e-based universal influenza vaccines: a historical overview and new approaches to development.
Mezhenskaya D; Isakova-Sivak I; Rudenko L
J Biomed Sci; 2019 Oct; 26(1):76. PubMed ID: 31629405
[TBL] [Abstract][Full Text] [Related]
54. How can we develop universal H5N1 vaccines.
Tan Y; He F; Kwang J
Immunotherapy; 2015; 7(7):713-6. PubMed ID: 26250411
[TBL] [Abstract][Full Text] [Related]
55. Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices - United States, 2020-21 Influenza Season.
Grohskopf LA; Alyanak E; Broder KR; Blanton LH; Fry AM; Jernigan DB; Atmar RL
MMWR Recomm Rep; 2020 Aug; 69(8):1-24. PubMed ID: 32820746
[TBL] [Abstract][Full Text] [Related]
56. The influenza virus enigma.
Salomon R; Webster RG
Cell; 2009 Feb; 136(3):402-10. PubMed ID: 19203576
[TBL] [Abstract][Full Text] [Related]
57. Neuraminidase as an influenza vaccine antigen: a low hanging fruit, ready for picking to improve vaccine effectiveness.
Eichelberger MC; Morens DM; Taubenberger JK
Curr Opin Immunol; 2018 Aug; 53():38-44. PubMed ID: 29674167
[TBL] [Abstract][Full Text] [Related]
58. The use of inactivated influenza vaccine in children.
Wright PF
Semin Pediatr Infect Dis; 2006 Oct; 17(4):200-5. PubMed ID: 17055371
[TBL] [Abstract][Full Text] [Related]
59. Report on the second WHO integrated meeting on development and clinical trials of influenza vaccines that induce broadly protective and long-lasting immune responses: Geneva, Switzerland, 5-7 May 2014.
Cox NJ; Hickling J; Jones R; Rimmelzwaan GF; Lambert LC; Boslego J; Rudenko L; Yeolekar L; Robertson JS; Hombach J; Ortiz JR
Vaccine; 2015 Nov; 33(48):6503-10. PubMed ID: 26478203
[TBL] [Abstract][Full Text] [Related]
60. Early Bird Gets the Flu: What Should Be Done About Waning Intraseasonal Immunity Against Seasonal Influenza?
Rambhia KJ; Rambhia MT
Clin Infect Dis; 2019 Mar; 68(7):1235-1240. PubMed ID: 30169619
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
